The HPA axis in HIV-1 infection.
Several lines of evidence suggest that neuroendocrine abnormalities in general and HPA axis activity in particular occur in both HIV-1 infection and individuals engaging in chronic drug use. For instance, our studies showing attenuated norepinephrine as well as ACTH and cortisol responses to a cold pressor challenge in asymptomatic HIV-1 persons support such a concept. Furthermore, our data on investigations on mirror-star tracing and speech challenges also support the finding that neuroendocrine responses are compromised in HIV-1 infection. Although the mechanisms leading to adverse effects on HPA axis activity in HIV infection are not fully understood, several lines of evidence suggest that a number of mechanisms may be involved, including homologies in molecular structures of various mediators of neuroendocrine activity and HIV-related structures, HIV as a chronic stress model, and virus-induced toxic factors. This article reviews our recent findings in this area and also presents research hypotheses needed for testing and understanding the mechanisms involved in the development of neuroendocrine abnormalities in HIV-1-infected injection drug users.
Kumar
Mahendra
M
Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, Florida 33101, USA. mkumar@med.miami.edu
Kumar
Adarsh M
AM
Waldrop
Drenna
D
Antoni
Michael H
MH
Schneiderman
Neil
N
Eisdorfer
Carl
C
D002395:Catecholamines / Q000097:blood; D005260:Female; D015658:HIV Infections / Q000503:physiopathology*; D015497:HIV-1; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology*; D008297:Male; D010913:Pituitary-Adrenal System / Q000503:physiopathology*; D015819:Substance Abuse, Intravenous / Q000150:complications*
D002395:Catecholamines